Literature DB >> 22258519

Apparent diffusion coefficient correlation with oesophageal tumour stroma and angiogenesis.

Tomoyoshi Aoyagi1, Kiyohiko Shuto, Shinichi Okazumi, Kohichi Hayano, Asami Satoh, Hiroshige Saitoh, Hideaki Shimada, Yoshihiro Nabeya, Toshiki Kazama, Hisahiro Matsubara.   

Abstract

OBJECTIVE: Because diffusion-weighted imaging (DWI) can predict the prognosis of patients with oesophageal squamous cell carcinoma (ESCC), we hypothesised that apparent diffusion coefficient (ADC) values might be correlated with the collagen content and tumour angiogenesis. The purpose of this study was to determine the correlation between ADC values of ESCC before treatment and oesophageal tumour stroma and angiogenesis.
METHODS: Seventeen patients with ESCC were enrolled. The ADC values were calculated from the DWI score. Seventeen patients who had undergone oesophagectomy were analysed for tumour stroma, vascular endothelial growth factor (VEGF) and CD34. Tissue collagen was stained with azocarmine and aniline blue to quantitatively analyse the extracellular matrix in cancer stroma. Tissues were stained with VEGF and CD34 to analyse the angiogenesis.
RESULTS: The ADC values decreased with stromal collagen growth. We found a negative correlation between the tumour ADC and the amount of stromal collagen (r = -0.729, P = 0.001), i.e. the ADC values decreased with growth of VEGF. We also found a negative correlation between the ADC of the tumours and the amount of VEGF (r = 0.538, P = 0.026).
CONCLUSION: Our results indicated that the ADC value may be a novel prognostic factor and contribute to the treatment of oesophageal cancer. KEY POINTS: • Magnetic resonance apparent diffusion coefficient values inversely indicate tumour stromal collagen • There is also negative correlation between ADCs and vascular endothelial growth factor • ADC values may contribute to the treatment of oesophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258519     DOI: 10.1007/s00330-011-2359-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

1.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

Authors:  M Nordsmark; M Overgaard; J Overgaard
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

2.  Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer.

Authors:  Tomoyoshi Aoyagi; Kiyohiko Shuto; Shinichi Okazumi; Hideaki Shimada; Toshiki Kazama; Hisahiro Matsubara
Journal:  Dig Surg       Date:  2011-06-03       Impact factor: 2.588

3.  Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.

Authors:  H Shimada; A Takeda; Y Nabeya; S I Okazumi; H Matsubara; Y Funami; H Hayashi; Y Gunji; S Kobayashi; T Suzuki; T Ochiai
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

4.  Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma.

Authors:  Satoshi Ohno; Mitsuo Tachibana; Toshiyuki Fujii; Shuhei Ueda; Hirofumi Kubota; Naofumi Nagasue
Journal:  Int J Cancer       Date:  2002-02-20       Impact factor: 7.396

5.  Oncotic pressure in solid tumors is elevated.

Authors:  M Stohrer; Y Boucher; M Stangassinger; R K Jain
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

Review 6.  High interstitial fluid pressure - an obstacle in cancer therapy.

Authors:  Carl-Henrik Heldin; Kristofer Rubin; Kristian Pietras; Arne Ostman
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

7.  The expression of type IV collagen alpha6 chain is related to the prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Yoshifumi Baba; Ken-Ichi Iyama; Koei Ikeda; Shinji Ishikawa; Naoko Hayashi; Nobutomo Miyanari; Yoshikazu Sado; Yoshifumi Ninomiya; Hideo Baba
Journal:  Ann Surg Oncol       Date:  2007-10-23       Impact factor: 5.344

8.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

Authors:  Y Boucher; L T Baxter; R K Jain
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

9.  Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.

Authors:  Matthew H Kulke; Robert D Odze; James D Mueller; Helen Wang; Mark Redston; Monica M Bertagnolli
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

10.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

Authors:  Taro Takahara; Yutaka Imai; Tomohiro Yamashita; Seiei Yasuda; Seiji Nasu; Marc Van Cauteren
Journal:  Radiat Med       Date:  2004 Jul-Aug
View more
  28 in total

1.  MR imaging in hepatocellular carcinoma: correlations between MRI features and molecular marker VEGF.

Authors:  Zhaoqin Huang; Xiangjiao Meng; Jianjun Xiu; Xiuqin Xu; Lei Bi; Jie Zhang; Xue Han; Qingwei Liu
Journal:  Med Oncol       Date:  2014-11-04       Impact factor: 3.064

2.  Intravoxel incoherent motion diffusion-weighted imaging of resectable oesophageal squamous cell carcinoma: association with tumour stage.

Authors:  Yu-Cheng Huang; Tian-Wu Chen; Xiao-Ming Zhang; Nan-Lin Zeng; Rui Li; Yu-Lian Tang; Fan Chen; Yan-Li Chen
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

3.  Accurate IVIM model-based liver lesion characterisation can be achieved with only three b-value DWI.

Authors:  P Mürtz; A M Sprinkart; M Reick; C C Pieper; A-H Schievelkamp; R König; H H Schild; W A Willinek; G M Kukuk
Journal:  Eur Radiol       Date:  2018-04-18       Impact factor: 5.315

4.  Intravoxel incoherent motion MR imaging of early cervical carcinoma: correlation between imaging parameters and tumor-stroma ratio.

Authors:  Xiangsheng Li; Ping Wang; Dechang Li; Hongxian Zhu; Limin Meng; Yunlong Song; Lizhi Xie; Jianping Zhu; Tao Yu
Journal:  Eur Radiol       Date:  2017-12-08       Impact factor: 5.315

5.  Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results.

Authors:  Iris-Melanie Noebauer-Huhmann; Gabriele Amann; Martin Krssak; Joannis Panotopoulos; Pavol Szomolanyi; Michael Weber; Christian Czerny; Martin Breitenseher; Guenther Grabner; Wolfgang Bogner; Stefan Nemec; Martin Dominkus; Philipp Funovics; Reinhard Windhager; Siegfried Trattnig
Journal:  Eur Radiol       Date:  2015-01-11       Impact factor: 5.315

6.  Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging.

Authors:  Xinxin Zhang; Yichen Wang; Jin Zhang; Xiaojuan Xu; Lianyu Zhang; Miaomiao Zhang; Lizhi Xie; Jianzhong Shou; Yan Chen
Journal:  Abdom Radiol (NY)       Date:  2022-03-20

7.  Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI.

Authors:  A-H Penner; A M Sprinkart; G M Kukuk; I Gütgemann; J Gieseke; H H Schild; W A Willinek; P Mürtz
Journal:  Eur Radiol       Date:  2013-05-11       Impact factor: 5.315

8.  Imaging for assessment of treatment response in hepatocellular carcinoma: Current update.

Authors:  Koichi Hayano; Sang Ho Lee; Dushyant V Sahani
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

9.  Preoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times.

Authors:  Anna Sophie Berghoff; Thomas Spanberger; Aysegül Ilhan-Mutlu; Manuel Magerle; Markus Hutterer; Adelheid Woehrer; Monika Hackl; Georg Widhalm; Karin Dieckmann; Christine Marosi; Peter Birner; Daniela Prayer; Matthias Preusser
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

Review 10.  Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques.

Authors:  Rajpaul Attariwala; Wayne Picker
Journal:  J Magn Reson Imaging       Date:  2013-08       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.